Active	Status	Sponsor type	Region	Phase	Filter
14 Active 12 Inactive 26 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Nurse, Research
NCT04302324: A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab	Recruiting	2	40	US	Daratumumab SC, Faspro, Clarithromycin, Pomalidomide, Dexamethasone	Weill Medical College of Cornell University, Janssen Scientific Affairs, LLC	Multiple Myeloma, Refractory Multiple Myeloma, Relapse Multiple Myeloma	09/25	09/30
PEMDA-HN, NCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC	Recruiting	2	81	Europe, US, RoW	Danvatirsen, ISIS 481464, AZD9150, Pembrolizumab, Keytruda	Flamingo Therapeutics NV	HNSCC	05/25	05/26
Ward, Teresa
No trials found
Sonney, Jennifer
No trials found
Kaneshiro, Jasmine
No trials found